{"id":"NCT04370548","sponsor":"Daré Bioscience, Inc.","briefTitle":"DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)","officialTitle":"A Phase 3 Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of DARE-BV1 in the Treatment of Bacterial Vaginosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-06-16","primaryCompletion":"2020-11-30","completion":"2020-12-07","firstPosted":"2020-05-01","resultsPosted":"2021-07-02","lastUpdate":"2022-12-08"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Vaginosis"],"interventions":[{"type":"DRUG","name":"DARE-BV1clindamycin phosphate vaginal gel, 2%","otherNames":["Placebo vaginal gel (HEC Universal Placebo Gel)"]}],"arms":[{"label":"Clindamycin phosphate vaginal gel, 2%","type":"EXPERIMENTAL"},{"label":"Placebo vaginal gel (Universal HEC Placebo Gel)","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, placebo-controlled study of DARE-BV1 (clindamycin phosphate vaginal gel, 2%) (QD x 1 day) compared to placebo vaginal gel (HEC Universal Placebo Gel) (QD × 1 day) for the treatment of bacterial vaginosis. Patients will be evaluated at three time points: a Day 1 Screening/Randomization visit, a Day 7-14 Interim Assessment visit, and a Day 21 - 30 Test of Cure \\[TOC\\] visit). Patients who discontinue prematurely from the study will receive a safety follow-up phone call between Day 21-30. The total study duration will be approximately one month for each individual patient.","primaryOutcome":{"measure":"Number of Patients With Clinical Cure at the TOC Visit (Day 21-30).","timeFrame":"Visit 3 Day 21-30 post randomization","effectByArm":[{"arm":"Clindamycin Phosphate Vaginal Gel, 2%","deltaMin":86,"sd":null},{"arm":"Placebo Vaginal Gel (Universal HEC Placebo Gel)","deltaMin":21,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["37098453","35675606"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":203},"commonTop":["Vulvovaginal candidiasis","Urinary tract infection","Vulvovaginal pruritus","Vaginal haemorrhage","Bacterial Vaginosis"]}}